|Year : 2016 | Volume
| Issue : 1 | Page : 78-82
Anti-Lipoxygenase activity of leaf gall extracts of Terminalia chebula (Gaertn.) Retz. (Combretaceae)
Ravi Shankara Birur Eshwarappa1, Yarappa Lakshmikantha Ramachandra2, Sundara Rajan Subaramaihha3, Sujan Ganapathy Pasura Subbaiah3, Richard Surendranath Austin4, Bhadrapura Lakkappa Dhananjaya5
1 Department of Chemistry, School of Graduate Studies, Jain University, Chamrajpete, Bengaluru, Karnataka; Research Unit in Vrukshayurveda, A Division of Center for Advanced Studies in Biosciences, Jain University, Chamrajpete, Bengaluru, Karnataka; Department of Studies and Research in Biotechnology, Kuvempu University, Shankarghatta, Karnataka, India
2 Department of Studies and Research in Biotechnology, Kuvempu University, Shankarghatta, Karnataka, India
3 Research Unit in Vrukshayurveda, A Division of Center for Advanced Studies in Biosciences, Jain University, Chamrajpete, Bengaluru, Karnataka, India
4 Department of Biochemistry, University of Mysore, Mysore, Karnataka, India
5 Department of Toxinology/Toxicology and Drug Discovery, Center for Emerging Technologies, Jain University, Kanakpura Taluk, Ramanagara, Karnataka, India
|Date of Web Publication||7-Dec-2015|
Dr. Bhadrapura Lakkappa Dhananjaya
Department of Toxinology/Toxicology and Drug Discovery, Center for Emerging Technologies Jain University, Karnataka
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Lipoxygenase (LOX) inhibitors are the promising therapeutic target for treating a wide spectrum of inflammatory-related diseases such as cancer, asthma, lymphoma, leukemia, and autoimmune disorders. In the present study, the photochemical constituents and the anti-LOX potential of leaf galls of Terminalia chebula are evaluated to exemplify its further potential development as medicine. Extracts of T. chebula galls were tested for anti-LOX activity using linoleic acid as substrate and lipoxidase as an enzyme and also the total content of polyphenols with phytochemical analysis of the extract were determined. The presence of highest total phenolic and flavonoid content of 141 ± 2.2 mg of gallic acid equivalent/g d.w and 125 ± 1.4 mg of quercetin equivalent/g d.w and maximal LOX inhibitory activity (52.67%) at 800 μg/mL concentrations were identified in the ethanolic extracts of leaf galls of T.chebula. The higher LOX inhibitory activity was positively correlated to the high content of total polyphenols/flavonoids. The results of this study confirm the folklore use of T. chebula leaves gall extracts as a natural anti-inflammatory agent and justify its ethnobotanical use. Therefore, the results encourage the use of T. chebula leave gall extracts for medicinal health, functional food, and nutraceuticals applications.
Keywords: Antioxidant, Anti-lipoxygenase, Drug, Gallic acid, Galls, Plants, Terminalia chebula
|How to cite this article:|
Eshwarappa RS, Ramachandra YL, Subaramaihha SR, Subbaiah SG, Austin RS, Dhananjaya BL. Anti-Lipoxygenase activity of leaf gall extracts of Terminalia chebula (Gaertn.) Retz. (Combretaceae). Phcog Res 2016;8:78-82
|How to cite this URL:|
Eshwarappa RS, Ramachandra YL, Subaramaihha SR, Subbaiah SG, Austin RS, Dhananjaya BL. Anti-Lipoxygenase activity of leaf gall extracts of Terminalia chebula (Gaertn.) Retz. (Combretaceae). Phcog Res [serial online] 2016 [cited 2020 Jan 23];8:78-82. Available from: http://www.phcogres.com/text.asp?2016/8/1/78/171103
The present investigation demonstrated promising anti-LOX properties of T. chebula leaves gall extracts. Presumably, these activities could be attributed in part to the polyphenolic features of the extract, as there was a strong correlation of higher LOX inhibiting activities with that of high total phenolic and flavonoid content in the methanolic leaf gall extracts of T. chebula. The results of this study confirm the folklore use of T. chebula leaves gall extracts as a natural anti-inflammatory agent and justify the ethnobotanical approach in the search for novel bioactive compounds.
| Introduction|| |
Lipoxygenases (LOXs) enzymes are reported to convert the arachidonic, linoleic, and other polyunsaturated fatty acid into biologically active metabolites that are involved in the inflammatory and immune responses.  It is noted that 5-LOX and platelet type 12-LOX are generally considered as pro-carcinogenic, 15-LOX-2 suppresses carcinogenesis while 15-LOX-1 remains controversial.  LOXs are the key enzymes in the biosynthesis of leukotrienes (LTs) that play an important role in several inflammation-related diseases such as arthritis, asthma, cancer, and allergic diseases. , High levels of LTs could be observed in the case of asthma, psoriasis, allergic rhinitis, rheumatoid arthritis, and colitis ulcerosa.  Therefore, it is of the view that the production of LTs can be prevented via inhibition of the LOX pathway and targeting LOX with inhibitors is of a promising therapeutic target for treating a wide spectrum of human diseases. Pidgeon et al.,  also suggested that LOX inhibitors may lead to the design of biologically and pharmacologically targeted therapeutic strategies inhibiting LOX isoforms and/or their biologically active metabolites which may be useful in cancer treatment.  Plants and plant based herbal preparations have been used to treat ailments since prehistoric times, and the treatment of various diseases with plant-based medicines has remained an integral part of many cultures across the globe. The World Health Organization estimates that 4 billion people (i.e., 80% of the world's population) use herbal medicines in some aspects of primary healthcare and there is a growing tendency to "go natural."  In these aspects, all around the world, the medicinal properties of plants have been investigated and explored for their potent biological activities to counteract diseases which are with no side effects and with high economic viability. ,,
Terminalia chebula (Gaertn.) Retz. (Combretaceae) commonly known as black myrobalan and haritaki, is an important medicinal plant native to tropical regions of southern Asia viz., India, Nepal, China, Sri Lanka, Malaysia, and Vietnam. It is amply referred to as "king of medicines" as it has been the component of many formulations for treatment of various diseases in all the streams of Indian system of medicines such as Ayurveda, Siddha, Unani, and Homeopathy. , It consists of gall-like excrescences formed by insects on the leaves, petioles, and branches of the plant-insect Dixothrips onerosus (Thysanoptera). The galls are vasiform, lobed, greenish yellow, fleshy, truncated gall, 25-33 mm long, smooth when immature, and longitudinally striated or ridged when old.  These galls are commonly known as Karkatshringi and is an important Ayurvedic drug used in preparations such as the dasamularista, Chyvanaprash and shringyadi churna which are used in the treatment of diseases like swasa (asthma), yakshma (tuberculosis), ajeerna (indigestion), hydroga (heart diseases), jwara (fevers), and yakrt roga (liver disorders) to mention a few. , Karkatshringi also finds usage in the treatment of children's ear infections, suppress hemorrhage from gums, and also used to suppress bleeding from the nose. , Hakims consider galls are useful in pulmonary infections, diarrhea, and vomiting.  The accepted source of Karkatasringi is the galls of Rhus Succedanea L., but Pistacia integerrima and T. chebula are also generally used in preparations. , Gall extracts of T. chebula have been found to possess anti-inflammatory, anti-bacterial, anti-tyrosinase, anti-cancer, and anti-aging activities. ,,,,, In the present study, the photochemical constituents and the anti-LOX potential of leaf galls of T. chebula are evaluated to exemplify its further potential development and use as a drug.
| Materials and Methods|| |
Lipoxidase (E.C.220.127.116.11), indomethacin, ascorbic acid, and gallic acid were purchased from Sigma, USA. Linoleic acid was purchased from Himedia. Ascorbic acid, gallic acid, quercetin, were procured from SRL Chemicals, India. All the other reagents and solvents were of analytical grade.
The gall induced leaves of T. chebula were purchased from local market of Bengaluru, India. The plant materials were certified and authenticated by Dr. S. Sundara Rajan, and the voucher specimen (JU-RUV-52) were deposited at Research Centre of Vrikshayurveda, Jain University, Bengaluru. Further letter of authentication of the plant material was provided by Vrikshayurveda Centre, Jain University dated 24 th May 2014. The galls were cleaned with distilled water, dried and crushed into fine powder by using an electric grinder.
Preparation of extract
The coarsely powdered gall materials were sequentially extracted with ethanol, petroleum ether, chloroform, and aqueous solvents in Soxhlet apparatus for 24 h. The extracts were evaporated to dryness under reduced pressure using a Rotavapor (BuchiFlawil, Switzerland) and a portion of the residue was used for the anti-LOX assay.
The preliminary qualitative phytochemical analyses of carbohydrates, saponins, alkaloids, flavonoids, fixed oils and fats, phenolic and tannins, glycosides, phytosterols, and triterpenoids in the extracts were carried out using the standard methods as described. ,,,,
Determination of total phenolic content
The total phenolics were determined in the T. chebula leaf gall extracts (ethanol, petroleum ether, chloroform, and aqueous) using Folin-Ciocalteu reagent method, employing gallic acid as a standard.  Briefly, 200 mL of both methanol and aqueous extracts (2 mg/mL) were made up to 3 mL with distilled water, and then mixed thoroughly with 0.5 mL of Folin-Ciocalteu reagent. After mixing for 3 min, 2 mL of 20% (W/V) sodium carbonate was added and allowed to stand for a further 60 min in the dark. The absorbance of the reaction mixtures was measured at 650 nm, and the results were expressed as mg of gallic acid equivalent (GAE)/g of dry weight.
Determination of total flavonoid content
Total flavonoid content of the extracts (ethanol, petroleum ether, chloroform, and aqueous) was determined using the aluminum chloride colorimetric method as described by Chang et al.  In brief, 50 μL of methanol and aqueous extracts (2 mg/mL) were made up to 1 mL with methanol then mixed with 4 mL of distilled water and subsequently with 0.3 mL of 5% NaNO 2 solution. After 5 min of incubation, 0.3 mL of 10% AlCl 3 solution was added and then allowed to stand for 6 min, followed by adding 2 mL of 1 M NaOH solution to the mixture. Then water was added to the mixture to bring the final volume to 10 mL, and the mixture was allowed to stand for 15 min. The absorbance was measured at 510 nm. Total flavonoid content was calculated as quercetin from a calibration curve. The calibration curve was prepared by preparing quercetin solutions at concentrations 12.5-100 mg/mL in methanol. The result was expressed as mg quercetin equivalent (QUE)/g of dry weight.
Anti-LOX assay was studied using linoleic acid as substrate and lipoxidase as enzyme purchased from Sigma, USA.  The plant extract sample (200-800 μg/mL) was dissolved in 0.25 mL of 2 M borate buffer pH 9.0 and added 0.25 mL of soybean lipoxidase enzyme solution (final concentration of 20,000 U/mL). This mixture was incubated for 5 min at 25°C. After which, 1.0 mL of linoleic acid solution (0.6 mM) was added, mixed well, and absorbance was measured at 234 nm. Indomethacin (60 μg/mL) was used as reference standard. The percent inhibition was calculated from the following equation:
% inhibition = ([Absorbance of control - Absorbance of test sample]/Absorbance of control) × 100
A dose-response curve was plotted to determine the IC values. IC 50 is defined as the concentration sufficient to obtain 50% of a maximum scavenging capacity. All tests and analyses were run in triplicate and averaged.
The experiments were carried out in triplicate and results are given as the mean ± standard deviation. Statistical analysis of all data was carried out using Microsoft Excel 2007 (MicroSoft;, Inc., USA) statistical software. Student's t-test was used to determine a significant difference between the experimental groups. Statistical significance was assumed at P = 0.05.
| Results and Discussion|| |
As LOXs are implicated in the biosynthesis of LTs that play an important role in several inflammation-related diseases such as arthritis, asthma, cancer, and allergic diseases; , therefore, it is of the view that the production of LTs can be prevented via inhibition of the LOX pathway and targeting LOX with inhibitors is of a promising therapeutic target. Results for LOX inhibitory activities of extracts (ethanol, petroleum ether, chloroform, and aqueous) of leaf galls of T. chebula are shown graphically in [Figure 1]. It is observed that the ethanol extract showed highest LOX inhibitory activity of 52.67% at 800 μg/mL concentration, whereas aqueous, chloroform, and petroleum ether extracts showed 46.31%, 39.51%, and 20.25% inhibition at the same concentration, respectively. The minimum inhibitory concentrations of the ethanol, petroleum ether, chloroform, and aqueous extracts of leaf galls of T. chebula, as well as those of standard antibiotics, are shown in [Table 1]. The results indicate that the ethanolic extract had potent inhibitory activities. The IC 50 value of ethanolic extract was found to be 560 ± 02 μg/mL. The reference standard indomethacin showed a 53.20% inhibition at a concentration of 60 μg/mL [Figure 1]. Therefore, in the present study, the methanol extract exhibited potent LOX inhibitory activity, when compared to all the other extracts and was equal to the standard used. These results suggest that leaf galls of T. chebula have a potentially high anti-inflammatory effect. Reactive oxygen species is known to propagate inflammation by stimulating the release of cytokines and also by activation of enzymes such as LOXs from inflammatory cells. Therefore, plants rich in antioxidant constituents with potential antioxidant activity are found to be beneficial to counteract inflammatory reactions. The antioxidant activities of plant/herb extracts are often explained by their total phenolic and flavonoid contents. The qualitative presence of phenolics, flavonoids, triterpenes, saponins, glycosides, phytosterols, and reducing sugars identified in the extracts are shown in [Table 2]. The total amount of phenolic and flavonoid content of extracts of leaf galls of T. chebula is presented in [Table 3]. The results obtained indicated that in comparison with all the exact, the ethanol extract had the highest total phenolic and flavonoid of 141 ± 2.2 mg of GAE/g d.w and 125 ± 1.4 mg of QUE/g d.w, respectively. These results show that the ethanol extract possessed significant activity in releasing most of the secondary metabolites from leave galls of T. chebula. This may be due to the fact that phenolic and flavonoid compounds are often extracted in higher amounts by using polar solvents such as aqueous methanol/ethanol.  It is reported that differences in the polarity of the extracting solvents could result in a wide variation in the polyphenolic and flavonoid contents of the extract. , Phenolic antioxidants are products of secondary metabolism in plants, and their antioxidant activity is mainly due to their redox properties and chemical structure, which can play an important role in chelating transitional metals and scavenging free radicals.  Similarly, the mechanisms of action of flavonoids are also through scavenging or chelating processes.  In addition, compounds such as flavonoids, which contain hydroxyl functional groups, are responsible for the antioxidant effects of plants.  The higher LOX inhibitory activity exhibited by ethanolic extract of T. chebula might be related to the significantly high polyphenolic content and antioxidant property. The leaf gall of T. chebula is reported to be very rich in tannins, triterpenoids, flavonoids, essential oils, and others phenolic constituents. , The results given in this investigation showed that the phenolic and flavonoid content was higher in polar extracts (ethanol) and subsequently its LOX inhibitory potential. Therefore, the inhibition might be due to the synergistic effect of the compounds from the extract. These observations confirm the folklore use of T. chebula leaves and gall extracts as a natural antioxidant and justify the ethnobotanical approach in the search for novel bioactive compounds.
|Figure 1: Lipoxygenase inhibitory activities of different extracts of leaf gall of Terminalia chebula. The plant extract sample (200–800 µg/mL) was preincubated with soybean lipoxidase enzyme (20,000 U/mL) for 5 min at 25°C. Linoleic acid solution (0.6 mM) was added, mixed well, and absorbance was measured at 234 nm. Indomethacin (60 µg/mL) was used as reference standard. Activity was measured and expressed as % inhibition. Each value is expressed as the mean ± standard deviation|
Click here to view
|Table 1: The MIC (µg/ml) of the petroleum ether, chloroform, aqueous, and ethanolic extracts of galls of Terminalia chebula and standard indomethacin against LOX enzyme activities|
Click here to view
|Table 2: Preliminary phytochemical analysis of leaf gall extracts of Terminalia chebula|
Click here to view
|Table 3: Total phenolic and total flavonoid content of Terminalia chebula leaf gall extracts|
Click here to view
| Conclusions|| |
The present investigation demonstrated promising anti-LOX properties of T. chebula leaves gall extracts. Presumably, these activities could be attributed in part to the polyphenolic features of the extract, as there was a strong correlation of higher LOX inhibiting activities with that of high total phenolic and flavonoid content in the methanolic leaf gall extracts of T. chebula. The results of this study confirm the folklore use of T. chebula leaves gall extracts as a natural anti-inflammatory agent and justify the ethnobotanical approach in the search for novel bioactive compounds. Further, the results support the use of gall extracts as a promising source that may be effective as preventive agents in the pathogenesis of some inflammatory diseases. Therefore, the results encourage the use of T. chebula leave gall extracts for medicinal health, functional food, and nutraceuticals applications. More in vivo and in vitro studies along with detailed phytochemical investigations are needed in order to potentially use this plant in the prevention and therapies of inflammatory-related diseases. In short, the present study provides the biochemical foundation for further chemical analysis and develop it as a drug for therapeutic application.
We acknowledge Dr. R. Chenraj Jain, President, Jain University Trust., Dr. N. Sundararajan, Vice Chancellor, Jain University, and Prof. K. S. Shantamani, Chief Mentor, Jain University, Bengaluru for their kind support and encouragement. DBL thank Jain University for the constant support and encouragement given toward research progress. DBL acknowledges the financial support by Tamil Nadu Science and Technology (Grant No. TNSCST/S and T Projects/VR/MS/2012-13/203) of Tamil Nadu State Council for Science and Technology to carry out this work.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Catalano A, Procopio A. New aspects on the role of lipoxygenases in cancer progression. Histol Histopathol 2005;20:969-75.
Pidgeon GP, Lysaght J, Krishnamoorthy S, Reynolds JV, O'Byrne K, Nie D, et al.
Lipoxygenase metabolism: Roles in tumor progression and survival. Cancer Metastasis Rev 2007;26:503-24.
Dobrian AD, Lieb DC, Cole BK, Taylor-Fishwick DA, Chakrabarti SK, Nadler JL. Functional and pathological roles of the 12- and 15-lipoxygenases. Prog Lipid Res 2011;50:115-31.
Rackova L, Oblozinsky M, Kostalova D, Kettmann V, Bezakova L. Free radical scavenging activity and lipoxygenase inhibition of Mahonia aquifolium
extract and isoquinoline alkaloids. J Inflamm (Lond) 2007;4:15.
Schneider I, Bucar F. Lipoxygenase inhibitors from natural plant sources. Part 1: Medicinal plants with inhibitory activity on arachidonate 5-lipoxygenase and 5-lipoxygenase [sol] cyclooxygenase. Phytother Res 2005;19:81-102.
Gossell-Williams M, Simon OR, West ME. The past and present use of plants for medicines. West Indian Med J 2006;55:217-8.
Auddy B, Ferreira M, Blasina F, Lafon L, Arredondo F, Dajas F, et al.
Screening of antioxidant activity of three Indian medicinal plants, traditionally used for the management of neurodegenerative diseases. J Ethnopharmacol 2003;84:131-8.
Shrestha S, Subaramaihha SR, Subbaiah SG, Eshwarappa RS, Lakkappa DB. Evaluating the antimicrobial activity of methonolic extract of Rhus succedanea
leaf gall. Bioimpacts 2013;3:195-8.
Shrestha S, Kaushik VS, Eshwarappa RS, Subaramaihha SR, Ramanna LM, Lakkappa DB. Pharmacognostic studies of insect gall of Quercus infectoria
). Asian Pac J Trop Biomed 2014;4:35-9.
CSIR. The Wealth of India, a Dictionary of Indian Raw Materials and Industrial Products. Vol. 8. New Delhi: Publication and Information Directorate, CSIR; 1969. p. 121.
Ministry of Health and Family Welfare. The Ayurvedic Formulary of India (Pt. I). 1 st
ed. Delhi: Department of Health, Government of India; 1978. p. 1-324.
Santha TR, Shetty JK, Yoganarasimhan SN, Sudha R. Farmacognostical studies on the South Indian market sample of karkatasringi (kadukkaipoo) - Terminalia chebul
(gaertn. Leaf gall) Anc Sci Life 1991;11:16-22.
Sukh D. Ethanotherapeutics and modern drug development. The potential of ayurveda. Curr Sci 1997;73:909-28.
Nadkarni KM. Indian Materia Medica. 3 rd
ed. Mumbai: Popular Prakashan Ltd.; 1976. p. 1062-3.
Ministry of Health and Family Welfare. The Siddha Formulary of India. New Delhi: Department of Health, Government of India; 1978a.
Vonshak A, Barazani O, Sathiyamoorthy P, Shalev R, Vardy D, Golan-Goldhirsh A. Screening South Indian medicinal plants for antifungal activity against cutaneous pathogens. Phytother Res 2003;17:1123-5.
Manosroi A, Jantrawut P, Akazawa H, Akihisa T, Manosroi J. Biological activities of phenolic compounds isolated from galls of Terminalia chebula
). Nat Prod Res 2010;24:1915-26.
Upadhye AS, Rajopadhye AA. Pharmacognostic and phytochemical evaluation of leaf galls of Kakadshringi used in Indian system of medicine. J Sci Indian Res 2010;69:700-4.
Manosroi A, Jantrawut P, Akihisa T, Manosroi W, Manosroi J. In vitro
and in vivo
skin anti-aging evaluation of gel containing niosomes loaded with a semi-purified fraction containing gallic acid from Terminalia chebula
galls. Pharm Biol 2011;49:1190-203.
Shankara BE, Ramachandra YL, Sundara Rajan S, Preetham J, Sujan Ganapathy PS. In vitro
antibacterial activity of Terminalia chebula
leaf gall extracts against some human pathogenic strains. Int Curr Pharm J 2012;1:217-20.
Manosroi A, Jantrawut P, Ogihara E, Yamamoto A, Fukatsu M, Yasukawa K, et al.
Biological activities of phenolic compounds and triterpenoids from the galls of Terminalia chebula
. Chem Biodivers 2013;10:1448-63.
Harborne JJ. Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis. 2 nd
ed. New York: Chapman and Hall; 1984. p. 85.
Trease GE, Evans WC. Pharmacognosy. 13 th
ed. Delhi: ELBS Publication; 1989. p. 171.
Kokate CK, Purohit AP, Gokhale SB. Pharmacognosy. 23 rd
ed. Pune: Nirali Prakashan; 1998. p. 106-14.
Khandelwal KR. Practical Pharmacognosy: Techniques and Experiments. 13 th
ed. Pune: Nirali Prakashan; 2005. p. 149-56.
Kaur C, Kapoor HC. Anti-oxidant activity and total phenolic content of some Asian vegetables. Int J Food Sci Technol 2002;37:153-61.
Chang C, Yang M, Wen H, Chern J. Estimation of total flavonoid content in propolis by two complementary colorimetric methods. J Food Drug Anal 2002;10:178-82.
Shinde UA, Kulkarni KR, Phadke AS, Nair AM, Mungantiwar AA, Dikshit VJ, et al.
Mast cell stabilizing and lipoxygenase inhibitory activity of Cedrus deodara
(Roxb.) Loud. wood oil. Indian J Exp Biol 1999;37:258-61.
Sultana B, Anwar F, Przybylski R. Antioxidant activity of phenolic components present in barks of barks of Azadirachta indica
, Terminalia arjuna
, Acacia nilotica
, and Eugenia jambolana
Lam trees. Food Chem 2007;104:1106-14.
Choi Y, Jeong HS, Lee J. Antioxidant activity of methanolic extracts from some grains consumed in Korea. Food Chem 2007;103:130-8.
Mohamed AA, Khalil AA, El-Beltagi HE. Antioxidant and antimicrobial properties of kaff maryam (Anastatica hierochuntica
) and doum palm (Hyphaene thebaica
). Grasas Y Aceites 2010;61:67-75.
Kessler M, Ubeaud G, Jung L. Anti- and pro-oxidant activity of rutin and quercetin derivatives. J Pharm Pharmacol 2003;55:131-42.
Das NP, Pereira TA. Effects of flavanoids on thermal autooxidation of palm oil: Structure activity relationship. J Am Oil Chem Soc 1990;67:255-8.
| Authors|| |
Dr. Ravi Shankara Birur Eshwarappa, has been working in the field of Drug discovery from diverse source from the past 8 years and has published over 10 International papers.
Dr. Yarappa Lakshmikantha Ramachandra, has been working in the field of Drug discovery from diverse source from the past 25 years and has published over 135 International papers.
Prof. Sundara Rajan Subaramaihha, has been working in the field of Drug discovery from the past 35 years and has published over 50 International papers.
Dr. Sujan Ganapathy Pasura Subbaiah, has been working in the field of Drug discovery from diverse source from the past 8 years and has published over 10 International papers.
Dr. Richard Surendranath Austin, has been working in the field of Drug discovery from diverse source from the past 5 years and has published over 8 International papers.
Dr. Bhadrapura Lakkappa Dhananjaya has been working in the field of Drug discovery from diverse source from the past 12 years and have published over 60 International papers.
[Table 1], [Table 2], [Table 3]